Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1981 Jun;73(2):393–399. doi: 10.1111/j.1476-5381.1981.tb10434.x

Differential responses to carbachol, sodium nitroprusside and 8-bromo-guanosine 3′,5′-monophosphate of canine atrial and ventricular muscle

Masao Endoh, Shuji Yamashita
PMCID: PMC2071677  PMID: 6263387

Abstract

1 The relation between force of contraction and cyclic nucleotide levels during muscarinic receptor stimulation, and after administration of sodium nitroprusside was assessed in canine isolated atrial and ventricular muscle.

2 The pD2 value (negative logarithm of ED50) for carbachol to decrease force of atrial contraction was similar to that required to inhibit adenosine 3′,5′-monophosphate (cyclic AMP)-mediated positive inotropic responses in ventricular muscle.

3 The cyclic AMP level of atrial muscle did not significantly change during carbachol-induced negative inotropic action, whilst the guanosine 3′,5′-monophosphate (cyclic GMP) level was elevated immediately after administration.

4 Sodium nitroprusside elevated cyclic GMP levels (without changing cyclic AMP levels) both in atrial and ventricular muscle. The force of atrial contraction was significantly reduced by the drug, whilst ventricular contractile force was unaffected.

5 8-Bromo-cyclic GMP markedly decreased contractile force in atrial muscle. In contrast, similar concentrations of 8-bromo-cyclic GMP had no effect on ventricular contractile force.

6 The positive inotropic action of phenylephrine on canine cardiac muscle, which is mediated through β-adrenoceptors, was unaffected either by sodium nitroprusside or by 8-bromo-cyclic GMP.

7 The present results suggest that the effect of muscarinic receptor stimulation in canine atrial and ventricular muscle is related to different changes in intracellular cyclic nucleotide metabolism. The direct myocardial depressant action on atrial muscle seems to be related to an elevation of cyclic GMP level, whilst a reduction of cyclic AMP may be responsible for the indirect action (`accentuated antagonism') in both atrial and ventricular muscle.

Full text

PDF
393

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biegon R. L., Pappano A. J. Dual mechanism for inhibition of calcium-dependent action potentials by acetylcholine in avian ventricular muscle. Relationship to cyclic AMP. Circ Res. 1980 Mar;46(3):353–362. doi: 10.1161/01.res.46.3.353. [DOI] [PubMed] [Google Scholar]
  2. Brooker G. Dissociation of cyclic GMP from the negative inotropic action of carbachol in guinea pig atria. J Cyclic Nucleotide Res. 1977 Dec;3(6):407–413. [PubMed] [Google Scholar]
  3. Brown B. S., Polson J. B., Krzanowski J. J., Wiggins J. R. Influence of isoproterenol and methylisobutylxanthine on the contractile and cyclic nucleotide effects of methacholine in isolated rat atria. J Pharmacol Exp Ther. 1980 Feb;212(2):325–332. [PubMed] [Google Scholar]
  4. Brown J. H. Cholinergic inhibition of catecholamine-stimulable cyclic AMP accumulation in murine atria. J Cyclic Nucleotide Res. 1979 Dec;5(6):423–433. [PubMed] [Google Scholar]
  5. Endoh M., Honma M. Effects of papaverine and its interaction with isoprenaline and carbachol on the contractile force and cyclic nucleotide levels of the canine ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol. 1979 Apr;306(3):241–248. doi: 10.1007/BF00507109. [DOI] [PubMed] [Google Scholar]
  6. Endoh M., Shimizu T. Failure of dibutyryl and 8-bromo-cyclic GMP to mimic the antagonistic action of carbachol on the positive inotropic effects of sympathomimetic amines in the canine isolated ventricular myocardium. Jpn J Pharmacol. 1979 Jun;29(3):423–433. doi: 10.1254/jjp.29.423. [DOI] [PubMed] [Google Scholar]
  7. Endoh M., Shimizu T., Yanagisawa T. Characterization of adrenoceptors mediating positive inotropic responses in the ventricular myocardium of the dog. Br J Pharmacol. 1978 Sep;64(1):53–61. doi: 10.1111/j.1476-5381.1978.tb08640.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Endoh M. The time course of changes in cyclic nucleotide levels during cholinergic inhibition of positive inotropic actions of isoprenaline and theophylline in the isolated canine ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol. 1980 Jun;312(2):175–182. doi: 10.1007/BF00569727. [DOI] [PubMed] [Google Scholar]
  9. Gardner R. M., Allen D. O. Regulation of cyclic nucleotide levels and glycogen phosphorylase activity by acetylcholine and epinephrine in perfused rat hearts. J Pharmacol Exp Ther. 1976 Aug;198(2):412–419. [PubMed] [Google Scholar]
  10. George W. J., Wilkerson R. D., Kadowitz P. J. Influence of acetylcholine on contractile force and cyclic nucleotide levels in the isolated perfused rat heart. J Pharmacol Exp Ther. 1973 Jan;184(1):228–235. [PubMed] [Google Scholar]
  11. HOLLENBERG M., CARRIERE S., BARGER A. C. BIPHASIC ACTION OF ACETYLCHOLINE ON VENTRICULAR MYOCARDIUM. Circ Res. 1965 Jun;16:527–536. doi: 10.1161/01.res.16.6.527. [DOI] [PubMed] [Google Scholar]
  12. Higgins C. B., Vatner S. F., Braunwald E. Parasympathetic control of the heart. Pharmacol Rev. 1973 Mar;25(1):119–155. [PubMed] [Google Scholar]
  13. Honma M., Satoh T., Takezawa J., Ui M. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue. Biochem Med. 1977 Dec;18(3):257–273. doi: 10.1016/0006-2944(77)90060-6. [DOI] [PubMed] [Google Scholar]
  14. Katsuki S., Arnold W. P., Murad F. Effects of sodium nitroprusside, nitroglycerin, and sodium azide on levels of cyclic nucleotides and mechanical activity of various tissues. J Cyclic Nucleotide Res. 1977 Aug;3(4):239–247. [PubMed] [Google Scholar]
  15. Keely S. L., Jr, Lincoln T. M., Corbin J. D. Interaction of acetylcholine and epinephrine on heart cyclic AMP-dependent protein kinase. Am J Physiol. 1978 Apr;234(4):H432–H438. doi: 10.1152/ajpheart.1978.234.4.H432. [DOI] [PubMed] [Google Scholar]
  16. Kohlhardt M., Haap K. 8-bromo-guanosine-3',5' -monophosphate mimics the effect of acetylcholine on slow response action potential and contractile force in mammalian atrial myocardium. J Mol Cell Cardiol. 1978 Jun;10(6):573–586. doi: 10.1016/0022-2828(78)90015-9. [DOI] [PubMed] [Google Scholar]
  17. Levy M. N. Sympathetic-parasympathetic interactions in the heart. Circ Res. 1971 Nov;29(5):437–445. doi: 10.1161/01.res.29.5.437. [DOI] [PubMed] [Google Scholar]
  18. Linden J., Brooker G. The questionable role of cyclic guanosine 3':5'-monophosphate in heart. Biochem Pharmacol. 1979 Dec 1;28(23):3351–3360. doi: 10.1016/0006-2952(79)90072-8. [DOI] [PubMed] [Google Scholar]
  19. Lugnier C., Stoclet J. C. Inhibition by papaverine of cGMP and cAMP phosphodiesterases from the rat heart. Biochem Pharmacol. 1974 Nov 1;23(21):3071–3074. doi: 10.1016/0006-2952(74)90285-8. [DOI] [PubMed] [Google Scholar]
  20. Nawrath H. Cyclic AMP and cyclic GMP may play opposing roles in influencing force of contraction in mammalian myocardium. Nature. 1976 Aug 5;262(5568):509–511. doi: 10.1038/262509b0. [DOI] [PubMed] [Google Scholar]
  21. Nawrath H. Evidence for opposing influences of cyclic GMP and cyclic AMP on force of contraction in mammalian myocardium. Recent Adv Stud Cardiac Struct Metab. 1976 May 26;11:419–422. [PubMed] [Google Scholar]
  22. Tsien R. W. Cyclic AMP and contractile activity in heart. Adv Cyclic Nucleotide Res. 1977;8:363–420. [PubMed] [Google Scholar]
  23. Watanabe A. M., Besch H. R., Jr Interaction between cyclic adenosine monophosphate and cyclic gunaosine monophosphate in guinea pig ventricular myocardium. Circ Res. 1975 Sep;37(3):309–317. doi: 10.1161/01.res.37.3.309. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES